Boho
Thinks s/he gets paid by the post
- Joined
- Feb 7, 2017
- Messages
- 1,844
On Thursday I read one analyst say that Biogen (BIIB) is now just an ordinary value stock due to the failure of their Alzheimer's drug. In the same article someone said he expects it to drop 20%, so when I saw it down around 26% I bought it (for $227.99). It dropped a little more that day but on Friday it started out up and got as high as $226.80. It's at $217.07 now. It sounds like they have to make some kind of move now and I expect any plan that they announce to be good news so I think it will work out at the price I paid.
With BA...um...my Buy to Cover price was met at some point and BA is still low enough but the Buy to Cover order disappeared so I still have to Buy to Cover. Hopefully Monday.
I bought CME for $175.98 and it's down to $163.32. I attempted to buy that one using my typical "method", unlike with BA and BIIB for which I used my second or third choice method, but I was a little out of practice and I'm not sure I would have bought it when I was in the zone. I did some further research after the buy and it seems OK I guess. I went on their website to get more detail on the info that I saw in the news that Fidelity gave me before I bought (about a lowering of some expectation in the company's guidance) but I couldn't find anything recent. I didn't dig deeper to see what's going on but I'm holding it for now.
With BA...um...my Buy to Cover price was met at some point and BA is still low enough but the Buy to Cover order disappeared so I still have to Buy to Cover. Hopefully Monday.
I bought CME for $175.98 and it's down to $163.32. I attempted to buy that one using my typical "method", unlike with BA and BIIB for which I used my second or third choice method, but I was a little out of practice and I'm not sure I would have bought it when I was in the zone. I did some further research after the buy and it seems OK I guess. I went on their website to get more detail on the info that I saw in the news that Fidelity gave me before I bought (about a lowering of some expectation in the company's guidance) but I couldn't find anything recent. I didn't dig deeper to see what's going on but I'm holding it for now.